The subcutaneous defibrillator

Current Treatment Options in Cardiovascular Medicine

Volumn 14, Issue 5, 2012, Pages 550-557

  Rowley, Christopher P ^a   Lobodzinski, S Suave ^b   Gold, Michael R ^a  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^b CALIFORNIA STATE UNIVERSITY   (United States)

Author keywords

ICD; Subcutaneous ICD; Sudden cardiac death

Indexed keywords

ARTICLE; BRUGADA SYNDROME; CARDIOMYOPATHY; CHANNELOPATHY; COMORBIDITY; CONGENITAL HEART DISEASE; CORONARY ARTERY DISEASE; DEFIBRILLATOR; DEVICE THERAPY; HEART RIGHT VENTRICLE DYSPLASIA; HIGH RISK PATIENT; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; IMMUNOCOMPROMISED PATIENT; IMPLANTABLE CARDIOVERTER DEFIBRILLATOR; INDWELLING CATHETER; LONG QT SYNDROME; MORBIDITY; MORTALITY; PATIENT CARE; PATIENT IDENTIFICATION; RISK ASSESSMENT; SUBCUTANEOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATOR; SUDDEN DEATH; TRANSVENOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATOR; TREATMENT INDICATION; VASCULAR ACCESS;

EID: 84870302390     PISSN: 10928464     EISSN: 15343189     Source Type: Journal    
DOI: 10.1007/s11936-012-0196-3     Document Type: Article

References (23)

1. MossAJ,ZarebaW, HallWJ, KleinH, WilberDJ, Cannom DS, et al. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med. 2002;346:877-83. (Pubitemid 34984635)
2. Bardy GH, Lee KL, Mark DB, Poole JE, Packer DL, Boineau R, et al. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med. 2005;352:225-37. (Pubitemid 40110811)
3. Alter P, Waldhans S, Plachta E, Moosdorf R, Grimm W. Complications of implantable cardioverter defibrillator therapy in 440 consecutive patients. Pacing Clin Electrophysiol. 2005;28:926-32. (Pubitemid 43960867)
4. van Rees JB, de Bie MK, Thijssen J, Borleffs CJ, Schalij MJ, van Erven L. Implantation-related complications of implantable cardioverter-defibrillators and cardiac resynchronization therapy devices a systematic review of randomized clinical trials. J Am Coll Cardiol. 2011;58:995-1000.
5. Maisel WH, Kramer DB. Implantable cardioverterdefibrillator lead performance. Circulation. 2008;117:2721-3.
6. Kleemann T, Becker T, Doenges K, Vater M, Senges J, Schneider S, et al. Annual rate of transvenous defibrillation lead defects in implantable cardioverterdefibrillators over a period of 910years. Circulation. 2007;115:2474-80. (Pubitemid 46763220)
7. Bardy GH, Smith WM, Hood MA, Crozier IG, Melton IC, Jordaens L, et al. An entirely subcutaneous implantable cardioverter-defibrillator. N Engl J Med. 2010;363:36-44.
8. Burke MC, Coman JA, Cates AW, Lindstrom CC, Sandler DA, Kim SS, et al. Defibrillation energy requirements using a left anterior chest cutaneous to subcutaneous shocking vector: Implications for a total subcutaneous implantable defibrillator. Hear Rhythm. 2005;2:1332-8. (Pubitemid 43055415)
9. Lieberman R, Havel WJ, Rashba E, DeGroot PJ, Stromberg K, Shorofsky SR. Acute defibrillation performance of a novel, non-transvenous shock pathway in adult icd indicated patients. Hear Rhythm. 2008;5:28-34.
10. Jolley M, Stinstra J, Tate J, Pieper S, Macleod R, Chu L, et al. Finite element modeling of subcutaneous implantable defibrillator electrodes in an adult torso. Hear Rhythm. 2010;7:692-8.
11. Dabiri Abkenari L, Theuns DA, Valk SD, Van Belle Y, de Groot NM, Haitsma D, et al. Clinical experience with a novel subcutaneous implantable defibrillator system in a single center. Clin Res Cardiol. 2011.
12. Lobodzinski SS. Subcutaneous implantable cardioverter-defibrillator (s-icd).Cardiol J. 2011;18:326-31.
13. Wathen MS, DeGroot PJ, Sweeney MO, Stark AJ, Otterness MF, Adkisson WO, et al. Prospective randomized multicenter trial of empirical antitachycardia pacing vs shocks for spontaneous rapid ventricular tachycardia in patients with implantable cardioverter-defibrillators: Pacing fast ventricular tachycardia reduces shock therapies (painfree rx ii) trial results. Circulation. 2004;110:2591-6. (Pubitemid 39453007)
14. van Rees JB, Borleffs CJ, de Bie MK, Stijnen T, van Erven L, Bax JJ, Schalij MJ. Inappropriate implantable cardioverter-defibrillator shocks: Incidence, predictors, and impact on mortality. J Am Coll Cardiol. 2011;57:556-62.
15. Daubert JP, Zareba W, Cannom DS, McNitt S, Rosero SZ, Wang P, et al. Inappropriate implantable cardioverter-defibrillator shocks in MADIT II: Frequency, mechanisms, predictors, and survival impact. J Am Coll Cardiol. 2008;51:1357-65. (Pubitemid 351443082)
16. Poole JE, Johnson GW, Hellkamp AS, Anderson J, Callans DJ, Raitt MH, et al. Prognostic importance of defibrillator shocks in patients with heart failure. N Engl J Med. 2008;359:1009-17.
17. Tang AS, Wells GA, Talajic M, Arnold MO, Sheldon R, Connolly S, et al. Cardiac-resynchronization therapy for mild-to-moderate heart failure. N Engl J Med. 2010;363:2385-95.
18. Moss AJ, Hall WJ, Cannom DS, Klein H, Brown MW, Daubert JP, et al. Cardiac-resynchronization therapy for the prevention of heart-failure events. N Engl J Med. 2009;361:1329-38.
19. Bristow MR, Saxon LA, Boehmer J, Krueger S, Kass DA, De Marco T, et al. Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure. N Engl J Med. 2004;350:2140-50.
20. Gold MR, Theuns DA, Knight BP, Sturdivant JL, Sanghera R, Ellenbogen KA, et al. Head-to-head comparison of arrhythmia discrimination performance of subcutaneous and transvenous icd arrhythmia detection algorithms: The START study. J Cardiovasc Electrophysiol. Article first published online: 28 Oct 2011.
21. Healey JS, Connolly SJ, Gold MR, Israel CW, Van Gelder IC, Capucci A, et al. Subclinical atrial fibrillation and the risk of stroke. N Engl J Med. 2012;366:120-9.
22. Glotzer TV, Daoud EG, Wyse DG, Singer DE, Ezekowitz MD, Hilker C, et al. The relationship between daily atrial tachyarrhythmia burden from implantable device diagnostics and stroke risk: The TRENDS study. Circ Arrhythm Electrophysiol. 2009;2:474-80.
23. Bernard ML, Gold MR. Meta-analysis of bleeding complications associated with cardiac rhythm device implantation. Circ Arrhythm Electrophysiol. 2012;5:168-74.